[Research progress of targeted therapy in non-small cell lung cancer brain metastases].

about

[Research progress of targeted therapy in non-small cell lung cancer brain metastases].

Item

http://www.wikidata.org/entity/Q54309216

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

[Research progress of targeted therapy in non-small cell lung cancer brain metastases].

@en

[Research progress of targeted therapy in non-small cell lung cancer brain metastases].

@nl

type

Item

label

[Research progress of targeted therapy in non-small cell lung cancer brain metastases].

@en

[Research progress of targeted therapy in non-small cell lung cancer brain metastases].

@nl

prefLabel

[Research progress of targeted therapy in non-small cell lung cancer brain metastases].

@en

[Research progress of targeted therapy in non-small cell lung cancer brain metastases].

@nl

P1476

[Research progress of targeted therapy in non-small cell lung cancer brain metastases].

@en

P2093

Caicun Zhou

http://www.w3.org/2001/XMLSchema#string

Tao Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.

The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

P304

824-828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2014.11.09

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25404274

http://www.w3.org/2001/XMLSchema#string

P932

6000351

http://www.w3.org/2001/XMLSchema#string